This journal has adopted the following models:
- Creative Commons Attribution License (CC-BY 2.0 UK)
- Publication Integrity and Ethics (P.I.E.) Guidelines
- Ethical Rules of Disclosure of the Association for Medical Ethics (AME)
- ICMJE Recommendations of the International Committee of Medical Journal Editors (ICMJE)
- Editorial Policy Statements of the Council of Science Editors (CSE)
Tracked/indexed by:
Google Scholar, JournalSeek, CrossRef, EZB Nutzeranfragen, RoMEO, AcademicKeys, CNKI, J-Gate
OAPL (UK) archiving provider: British Library
Our publisher has negotiated a discount for its editors, reviewers and authors to undertake (distant learning- fully online) short courses related to research integrity and publication ethics, law and medical ethics, research governance, good ethical practice, leadership and management. These courses are approved by the Publication Integrity & Ethics.
A UK-based not-for-profit organization promoting integrity and ethics in the publishing sector through its guidelines and code of conduct.
P.I.E.'s main aim is to pave the way for a better publishing ethical environment that sets out the standards of a good and ethical editorial behaviour.
Whilst P.I.E. (π) promotes editorial freedom, at the same time, it also ensures that this freedom is not violated by editorial misconduct and plagiarism.
OAPL authors may choose to include the
OAPL standard ethics statements
in their submitted articles. It is assumed that all submitted original research studies, research studies, hypothesis, methodologies, short communications, case studies, case reports & case series have been conducted to the highest ethical standards.
Dembinski D, Oren L, Gutmark E, Khosla S. Biomechanical measurements of vocal fold elasticity. OA Tissue Engineering 2014 Feb 22;2(1):3.
Level IIa
van Spreeuwel ACC, Bax NAM, Bouten CVC. The relevance of extracellular matrix structure and composition in engineering the diseased cardiac microenvironment. OA Tissue Engineering 2014 Jan 18;2(1):2.
High Impact
Li X, Mao HQ. Bioengineering endogenous neural stem cells for central nervous system regeneration. OA Tissue Engineering 2014 Jan 18;2(1):1.
High Impact
Kristjánsson B, Honsawek S. Current trends of stem cell-based approaches for knee osteoarthritis. OA Tissue Engineering 2013 Jun 01;1(1):7.
High Impact
Chan KH, Zhuo S, Ni M. Natural and synthetic peptide-based biomaterials for bone tissue engineering. OA Tissue Engineering 2013 May 01;1(1):6.
High Impact
Lee YJ, Kim GM. Tunable electrospun scaffolds on cell behaviour for tissue regeneration and drug delivery system. OA Tissue Engineering 2013 May 01;1(1):5.
High Impact
Ricci C, Moroni L, Danti S. Cancer tissue engineeringnew perspectives in understanding the biology of solid tumoursa critical review. OA Tissue Engineering 2013 Apr 01;1(1):4.
High Impact
Li Z, He C, Xiao J, Chen ZY. Treating end-stage liver diseases with mesenchymal stem cells: An oak is not felled at one stroke. OA Tissue Engineering 2013 Apr 01;1(1):3.
High Impact
Huang HS, Hsu SH. Current advances of stem cell-based approaches to tissue-engineered vascular grafts. OA Tissue Engineering 2013 Mar 01;1(1):2.
High Impact
Almelkar SI, Kadam SS, Diwate S, Chaukar A, Bhonde RR, Patwardhan AM. Re-endothelialization of biological tissue-engineered conduits and scaffold for its potential use in bioprosthesis. OA Tissue Engineering 2013 Mar 01;1(1):1.
High Impact
Li Z, He C, Xiao J, Chen ZY. Treating end-stage liver diseases with mesenchymal stem cells: An oak is not felled at one stroke. OA Tissue Engineering 2013 Apr 01;1(1):3.
High Impact
Ricci C, Moroni L, Danti S. Cancer tissue engineeringnew perspectives in understanding the biology of solid tumoursa critical review. OA Tissue Engineering 2013 Apr 01;1(1):4.
High Impact
Huang HS, Hsu SH. Current advances of stem cell-based approaches to tissue-engineered vascular grafts. OA Tissue Engineering 2013 Mar 01;1(1):2.
High Impact
Almelkar SI, Kadam SS, Diwate S, Chaukar A, Bhonde RR, Patwardhan AM. Re-endothelialization of biological tissue-engineered conduits and scaffold for its potential use in bioprosthesis. OA Tissue Engineering 2013 Mar 01;1(1):1.
High Impact
van Spreeuwel ACC, Bax NAM, Bouten CVC. The relevance of extracellular matrix structure and composition in engineering the diseased cardiac microenvironment. OA Tissue Engineering 2014 Jan 18;2(1):2.
High Impact
Kristjánsson B, Honsawek S. Current trends of stem cell-based approaches for knee osteoarthritis. OA Tissue Engineering 2013 Jun 01;1(1):7.
High Impact
Chan KH, Zhuo S, Ni M. Natural and synthetic peptide-based biomaterials for bone tissue engineering. OA Tissue Engineering 2013 May 01;1(1):6.
High Impact
Lee YJ, Kim GM. Tunable electrospun scaffolds on cell behaviour for tissue regeneration and drug delivery system. OA Tissue Engineering 2013 May 01;1(1):5.
High Impact
Li X, Mao HQ. Bioengineering endogenous neural stem cells for central nervous system regeneration. OA Tissue Engineering 2014 Jan 18;2(1):1.
High Impact
Dembinski D, Oren L, Gutmark E, Khosla S. Biomechanical measurements of vocal fold elasticity. OA Tissue Engineering 2014 Feb 22;2(1):3.
Level IIa
Dembinski D, Oren L, Gutmark E, Khosla S. Biomechanical measurements of vocal fold elasticity. OA Tissue Engineering 2014 Feb 22;2(1):3.
Level IIa
van Spreeuwel ACC, Bax NAM, Bouten CVC. The relevance of extracellular matrix structure and composition in engineering the diseased cardiac microenvironment. OA Tissue Engineering 2014 Jan 18;2(1):2.
High Impact
Li X, Mao HQ. Bioengineering endogenous neural stem cells for central nervous system regeneration. OA Tissue Engineering 2014 Jan 18;2(1):1.
High Impact
Kristjánsson B, Honsawek S. Current trends of stem cell-based approaches for knee osteoarthritis. OA Tissue Engineering 2013 Jun 01;1(1):7.
High Impact
Chan KH, Zhuo S, Ni M. Natural and synthetic peptide-based biomaterials for bone tissue engineering. OA Tissue Engineering 2013 May 01;1(1):6.
High Impact
Lee YJ, Kim GM. Tunable electrospun scaffolds on cell behaviour for tissue regeneration and drug delivery system. OA Tissue Engineering 2013 May 01;1(1):5.
High Impact
Ricci C, Moroni L, Danti S. Cancer tissue engineeringnew perspectives in understanding the biology of solid tumoursa critical review. OA Tissue Engineering 2013 Apr 01;1(1):4.
High Impact
Li Z, He C, Xiao J, Chen ZY. Treating end-stage liver diseases with mesenchymal stem cells: An oak is not felled at one stroke. OA Tissue Engineering 2013 Apr 01;1(1):3.
High Impact
Huang HS, Hsu SH. Current advances of stem cell-based approaches to tissue-engineered vascular grafts. OA Tissue Engineering 2013 Mar 01;1(1):2.
High Impact
Almelkar SI, Kadam SS, Diwate S, Chaukar A, Bhonde RR, Patwardhan AM. Re-endothelialization of biological tissue-engineered conduits and scaffold for its potential use in bioprosthesis. OA Tissue Engineering 2013 Mar 01;1(1):1.
High Impact
